Bell Ceremonies

Acumen Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell

Published

Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimer’s disease (AD), visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Daniel O’Connell, President and Chief Executive Officer at Acumen, rings the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now